Effect of Allopregnanolone on Stress-induced Craving
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine whether intravenous infusion of allopregnanolone
(ALLO) attenuates stress-induced craving and stress-induced anxiety in a clinical laboratory
setting. The secondary objective of this project is to characterize the behavioral effects of
ALLO in heavy drinkers.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)